Tiziana Life Sciences (TLSA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tiziana Life Sciences is set to offer up to $10 million in common shares, as confirmed by their Bermuda counsel. The shares will be issued under a securities purchase agreement and are declared validly issued and fully paid. This move could present an intriguing opportunity for investors keeping an eye on the biotech sector.
For further insights into TLSA stock, check out TipRanks’ Stock Analysis page.
